Inspire Medical Systems Hits New 52-Week Low at $50.67

Inspire Medical Systems, Inc., a small-cap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 50.67 on March 24, 2026. This significant decline reflects a challenging year for the company, with a performance drop of 67.65% over the past year, contrasting sharply with the S&P 500's gain of 13.68% during the same period. The company's market capitalization stands at USD 1,683 million, indicating its position within the small-cap category. Inspire Medical Systems has a price-to-earnings (P/E) ratio of 11.00, which may suggest a valuation that is lower than some of its peers in the industry. Additionally, the company has a return on equity of 19.13%, showcasing its ability to generate profits from shareholders' equity. Despite the current low price, Inspire Medical Systems maintains a price-to-book ratio of 2.15, and it does not offer a dividend yield. The company's debt-to-equity ratio is reported at -0.39, indicating a unique financial structure. As the stock navigates these market conditions, its performance metrics will be closely monitored by stakeholders.